Table 1.
Sociodemographic and clinical characteristics.
| Subjects with schizophrenia | Normal control subjects | |||
|---|---|---|---|---|
| Women (N = 21) |
Men (N = 22) |
Women (N = 21) |
Men (N = 22) |
|
| Age (years) (mean and SD) | 32.86 (6.56) | 31.36 (7.36) | 29.28 (9.27) | 30.55 (7.81) |
| Parental SES (mean and SD) | 2.54 (1.05) | 2.79 (0.75) | 2.08 (1.10) | 2.43 (1.11) |
| Handedness, no. right (%) (mean and SD) | 21 (86.15) | 18 (60.47) | 21 (65.39) | 18 (54.36) |
| Age at onset (mean and SD) | 24.29 (6.14) | 20.38 (3.90)** | ||
| Duration of Illness years (mean and SD) | 8.14 (5.66) | 10.95 (7.64) | ||
| Chlorpromazine equivalents, mg (mean and SD) | 467.06 (292.26) | 693.18 (378.41)** | ||
| PANSS positive (mean and SD) | 19.32 (7.82) | 18.18 (5.51) | ||
| PANSS negative (mean and SD) | 20.14 (8.69) | 20.09 (5.45) | ||
| PANSS general (mean and SD) | 42.27 (12.72) | 39.32 (6.02) | ||
| Subjective rating positive (mean and SD) | 4.75 (1.20) | 4.95 (1.35) | 5.06 (0.95) | 4.38 (1.15) |
| Subjective rating negative (mean and SD) | 5.14 (1.24) | 5.36 (1.17) | 5.75 (0.58) | 5.04 (1.06) |
**Significant P < 0.05.